GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Varex Imaging Corp (NAS:VREX) » Definitions » EBITDA

Varex Imaging (Varex Imaging) EBITDA : $80.9 Mil (TTM As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Varex Imaging EBITDA?

Varex Imaging's EBITDA for the three months ended in Mar. 2024 was $17.8 Mil. Its EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was $80.9 Mil.

During the past 12 months, the average EBITDA Growth Rate of Varex Imaging was -22.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 11 years, the highest 3-Year average EBITDA Growth Rate of Varex Imaging was 11.90% per year. The lowest was -14.80% per year. And the median was -12.45% per year.

Varex Imaging's EBITDA per Share for the three months ended in Mar. 2024 was $0.43. Its EBITDA per share for the trailing twelve months (TTM) ended in Mar. 2024 was $1.83.

During the past 12 months, the average EBITDA per Share Growth Rate of Varex Imaging was -28.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per share growth rate using EBITDA per Share data.

During the past 11 years, the highest 3-Year average EBITDA per Share Growth Rate of Varex Imaging was 9.10% per year. The lowest was -14.50% per year. And the median was -12.55% per year.


Varex Imaging EBITDA Historical Data

The historical data trend for Varex Imaging's EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Varex Imaging EBITDA Chart

Varex Imaging Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 81.80 -8.70 104.50 114.50 91.20

Varex Imaging Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.50 32.10 16.30 14.70 17.80

Competitive Comparison of Varex Imaging's EBITDA

For the Medical Devices subindustry, Varex Imaging's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Varex Imaging's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Varex Imaging's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Varex Imaging's EV-to-EBITDA falls into.


Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Varex Imaging's EBITDA for the fiscal year that ended in Sep. 2023 is calculated as

Varex Imaging's EBITDA was directly provided by GuruFocus' data source Morningstar. For the fiscal year ended in Sep. 2023, Varex Imaging's EBITDA was $91.2 Mil.

Varex Imaging's EBITDA for the quarter that ended in Mar. 2024 is calculated as

Varex Imaging's EBITDA was directly provided by GuruFocus' data source Morningstar. For the quarter ended in Mar. 2024, Varex Imaging's EBITDA was $17.8 Mil.

EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $80.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sometimes companies may have already deducted Depreciation and Amortization from Gross Profit. In this case Depreciation and Amortization needs to be added back when calculating EBITDA.

Varex Imaging  (NAS:VREX) EBITDA Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals Operating Income. Operating Income is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses.. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies. Also Price-to-EBITDA is sometimes used in valuations.


Varex Imaging EBITDA Related Terms

Thank you for viewing the detailed overview of Varex Imaging's EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Varex Imaging (Varex Imaging) Business Description

Traded in Other Exchanges
Address
1678 South Pioneer Road, Salt Lake City, UT, USA, 84104
Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital flat panel image detectors, high voltage connectors, ionization chambers, and buckys among others. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors and high voltage connectors among others. It has manufacturing, research, and development operation in the United States, Europe, Philippines and China, and sales and service operations throughout the world.
Executives
Kimberley E. Honeysett officer: Vice President and Secretary 1678 S. PIONEER ROAD, SALT LAKE CITY UT 84104
Jay K. Kunkel director 21557 TELEGRAPH ROAD, SOUTHFIELD MI 48033
Ruediger Naumann-etienne director
Kathleen Bardwell director 9 BLACKBERRY DRIVE, HUDSON OH 44236
Sunny Sanyal director, officer: President and CEO 1678 S. PIONEER ROAD, SALT LAKE CITY UT 84104
Kevin Bruce Yankton officer: Controller & CAO 1678 S. PIONEER ROAD, SALT LAKE CITY UT 84104
Andrew Hartmann officer: SVP Sales & Marketing, Medical 1678 S. PIONEER ROAD, SALT LAKE CITY UT 84104
Timothy E Guertin director C/O VARIAN MEDICAL SYSTEMS, INC, 3100 HANSEN WAY M/S E-327, PALO ALTO CA 94304
Shubham Maheshwari officer: Chief Financial Officer C/O VEECO INSTRUMENTS INC., 1 TERMINAL DRIVE, PLAINVIEW NY 11803
Brian W Giambattista officer: SVP and GM, X-ray Detectors 1678 SOUTH PIONEER ROAD, SALT LAKE CITY UT 84104
Erich R Reinhardt director VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 94304
Mark S. Jonaitis officer: SVP and GM, X-Ray Sources 1678 S. PIONEER ROAD, SALT LAKE CITY UT 84104
Clarence R Verhoef officer: SVP & Chief Financial Officer VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 95035
Rosebrough Walter M Jr director 5960 HEISLEY ROAD, MENTOR OH 44060
Carl E. Lacasce officer: SVP, Sales & Marketing 1678 S. PIONEER ROAD, SALT LAKE CITY UT 84104